Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03159533 · ClinicalTrials.gov registry record · NA

Project IMPACT: CHW Intervention

A NA study of Hypertension, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
305
Enrollment target
1
Study location

NCT03159533 is a NA study of Hypertension that has completed, run by NYU Langone Health. The registered enrollment target is 305 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03159533, a NA study of Hypertension, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
305 participants
Enrollment target
1
Study location

Study Summary

The proposed study "Project IMPACT: CHW Intervention" is part of a larger study examining the efficacy, adoption, and impact of integrated EHR-based decision-support and physician feedback interventions with community health worker (CHW)-led self-management and coaching support for South Asian patients with uncontrolled hypertension. This is a randomized control intervention utilizing community health worker (CHW)-led self-management and coaching support for South Asian patients with uncontrolled hypertension at PCP clinics in New York City.

Conditions Studied

Interventions

  • BEHAVIORAL CHW Intervention
  • BEHAVIORAL Wait List Control Group

Study Locations (1)

New York

  • New York University School of Medicine - New York

Trial Details

FieldValue
Enrollment Target 305 participants
Start Date 2017-03-09
Est. Completion 2019-07-01
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03159533

The ClinicalTrials.gov registry entry for NCT03159533 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 305 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which CHW Intervention is the first listed.

NCT03159533 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03159533 about?

NCT03159533 is a clinical study titled "Project IMPACT: CHW Intervention". The proposed study "Project IMPACT: CHW Intervention" is part of a larger study examining the efficacy, adoption, and impact of integrated EHR-based decision-support and physician feedback interventions with community health worker (CHW)-led self-management and coaching support for South Asian patie...

What is the current status of trial NCT03159533?

This trial is currently completed. It is a NA study. The enrollment target is 305 participants. The study started on 2017-03-09. Estimated completion is 2019-07-01.

What conditions does trial NCT03159533 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT03159533?

The interventions under investigation include: CHW Intervention (BEHAVIORAL), Wait List Control Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT03159533?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03159533 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.